Retour
Fourchette du Jour
29,64 €
30,42 €
Fourchette 52 Semaines
28,29 €
43,18 €
Volume
479 129
Moyenne 50J / 200J
34,28 €
/
35,10 €
Clôture Précédente
29,18 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -129,6 | 0,4 |
| P/B | 3,0 | 2,9 |
| ROE % | -2,4 | 3,7 |
| Net Margin % | -2,1 | 3,8 |
| Rev Growth 5Y % | 18,2 | 10,0 |
| D/E | 0,2 | 0,2 |
Points Clés
Revenue grew 18,15% annually over 5 years — strong growth
Debt/Equity of 0,18 — conservative balance sheet
Generating 48,28M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,27%
Capital efficient — spends only 1,69% of revenue on capex
Croissance
Revenue Growth (5Y)
18,15%
Revenue (1Y)14,88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-2,40%
ROIC-0,45%
Net Margin-2,14%
Op. Margin-0,64%
Sécurité
Debt / Equity
0,18
Current Ratio3,96
Interest Coverage-0,59
Valorisation
P/E Ratio
-129,57
P/B Ratio3,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14,88% | Revenue Growth (3Y) | 15,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18,15% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 534,53M | Net Income (TTM) | -11,45M |
| ROE | -2,40% | ROA | -1,75% |
| Gross Margin | 74,41% | Operating Margin | -0,64% |
| Net Margin | -2,14% | Free Cash Flow (TTM) | 48,28M |
| ROIC | -0,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,18 | Current Ratio | 3,96 |
| Interest Coverage | -0,59 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -129,57 | P/B Ratio | 3,02 |
| P/S Ratio | 2,78 | PEG Ratio | 2,21 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,48B | Enterprise Value | 1,40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 534,53M | 465,31M | 399,25M | 330,38M | 274,33M |
| Net Income | -11,45M | -44,70M | -30,44M | -46,47M | 50,20M |
| EPS (Diluted) | -0,24 | -0,95 | -0,66 | -1,02 | 1,09 |
| Gross Profit | 397,74M | 347,52M | 300,37M | 245,94M | 205,86M |
| Operating Income | -3,45M | -40,01M | -26,68M | -42,67M | 55,21M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 654,18M | 609,33M | 613,93M | 585,45M | 615,31M |
| Total Liabilities | 162,24M | 148,36M | 147,76M | 128,69M | 131,56M |
| Shareholders' Equity | 491,94M | 460,97M | 466,17M | 456,75M | 483,76M |
| Total Debt | 88,02M | 76,53M | 74,49M | 74,55M | 75,65M |
| Cash & Equivalents | 167,43M | 122,72M | 84,31M | 58,10M | 43,65M |
| Current Assets | 322,52M | 267,83M | 266,25M | 215,21M | 196,08M |
| Current Liabilities | 81,52M | 73,42M | 74,57M | 58,39M | 56,45M |